课题基金 / 基金详情

Efficacy and safety of methylxanthines in very low birthweight infants

甲基黄嘌呤类药物对极低出生体重婴儿的疗效和安全性

批准号：

189324

负责人：

Schmidt Barbara K

金额：

$148.48万

依托单位：

McMaster University

依托单位国家：

加拿大

项目类别：

Operating Grants

财政年份：

2009

资助国家：

加拿大

项目状态：

已结题

起止时间：

2009-09-01 至 2014-09-01

来源：

https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=189324&lang=en

关键词：

Apnea Of Prematurity Drug Safety Methylxanthines (Caffeine) Randomized Clinical Trial School-Age Function Very Low Birth Weight Infants

项目摘要

项目成果

相似基金

相关文献

中文摘要

翻译

点击翻译按钮获取中文摘要

英文摘要

At least 5 of every 1000 live-born babies are very preterm and weigh only 500 to 1250 grams at birth. Approximately 50% of the surviving children have serious school difficulties and require special educational assistance. The aim of this research is to r

期刊论文(0)

专著(0)

科研奖励(0)

会议论文